VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CCThe Chemours Company
$20.74$3.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCCQuarterly Financials

The Chemours Company (CC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

The Chemours Company (CC) quarterly income statement — complete revenue, gross profit & net income history

CC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue1.38B1.33B1.5B1.61B1.37B1.39B1.5B1.55B1.36B1.41B1.49B1.64B
Revenue Growth %0.95%-4.59%-0.4%3.93%0.44%-1.27%0.94%-5.42%-11.33%5.53%-16.32%-14.2%
Cost of Goods Sold1.17B1.18B1.26B1.34B1.13B1.12B1.22B1.25B1.08B1.16B1.21B1.23B
COGS % of Revenue84.65%88.5%84.28%82.79%82.75%80.42%80.95%80.18%79.15%81.94%81.64%75.05%
Gross Profit212M153M235M278M236M273M286M308M284M255M273M410M
Gross Margin %15.35%11.5%15.72%17.21%17.25%19.58%19.05%19.82%20.85%18.06%18.36%24.95%
Gross Profit Growth %-10.17%-43.96%-17.83%-9.74%-16.9%7.06%4.76%-24.88%-22.83%26.24%-36.81%-17.51%
Operating Expenses173M412M131M206M158M198M164M178M171M148M163M215M
OpEx % of Revenue12.53%30.98%8.76%12.76%11.55%14.2%10.93%11.45%12.56%10.48%10.96%13.09%
Selling, General & Admin147M676M00123M169M135M0139M000
SG&A % of Revenue10.64%50.83%--8.99%12.12%8.99%-10.21%---
Research & Development26M27M26M28M27M26M29M26M28M15M28M28M
R&D % of Revenue1.88%2.03%1.74%1.73%1.97%1.87%1.93%1.67%2.06%1.06%1.88%1.7%
Other Operating Expenses0-1000K1000K1000K1000K1000K01000K1000K1000K1000K1000K
Operating Income39M-259M104M72M78M75M122M130M113M107M110M195M
Operating Margin %2.82%-19.47%6.96%4.46%5.7%5.38%8.13%8.37%8.3%7.58%7.4%11.87%
Operating Income Growth %-50%-445.33%-14.75%-44.62%-30.97%-29.91%10.91%-33.33%-48.17%2775%-57.53%-11.36%
EBITDA39M-506M183M152M166M153M200M204M184M181M186M273M
EBITDA Margin %2.82%-38.05%12.24%9.41%12.13%10.98%13.32%13.13%13.51%12.82%12.51%16.62%
EBITDA Growth %-76.51%-430.72%-8.5%-25.49%-9.78%-15.47%7.53%-25.27%-38.05%158.57%-43.64%-6.51%
D&A (Non-Cash Add-back)0-247M79M80M88M78M78M74M71M74M76M78M
EBIT39M-76M119M72M66M76M39M130M133M96M110M195M
Net Interest Income0-69M-68M-66M-66M-67M-69M-66M-63M-63M-55M-48M
Interest Income000000000000
Interest Expense-69M69M68M66M66M67M69M66M63M63M55M48M
Other Income/Expense-61M114M-53M-333M0-66M-152M-61M-43M-176M-97M-628M
Pretax Income-22M-145M51M-261M78M9M-30M69M70M-69M13M-433M
Pretax Margin %-1.59%-10.9%3.41%-16.16%5.7%0.65%-2%4.44%5.14%-4.89%0.87%-26.35%
Income Tax7M-83M-9M119M82M17M-3M9M16M-53M1M-57M
Effective Tax Rate %-31.82%57.24%-17.65%-45.59%105.13%188.89%10%13.04%22.86%76.81%7.69%13.16%
Net Income-29M-61M60M-381M-4M-8M-27M60M54M-18M12M-376M
Net Margin %-2.1%-4.59%4.01%-23.59%-0.29%-0.57%-1.8%3.86%3.96%-1.27%0.81%-22.88%
Net Income Growth %-625%-662.5%322.22%-735%-107.41%55.56%-325%115.96%-62.76%81.44%-95%-287.06%
Net Income (Continuing)-29M-62M60M-380M-4M-8M-27M60M54M-16M12M-376M
Discontinued Operations000000000000
Minority Interest1M1M2M2M1M1M2M2M2M2M2M2M
EPS (Diluted)-0.19-0.390.40-2.54-0.03-0.05-0.180.470.34-0.170.13-2.52
EPS Growth %-611.61%-630.34%322.22%-640.43%-107.85%68.59%-238.46%118.65%-64.58%73.85%-91.45%-300%
EPS (Basic)-0.19-0.400.40-2.54-0.03-0.05-0.180.470.35-0.170.13-2.52
Diluted Shares Outstanding150.55M150.55M150.24M150.24M150.41M149.83M149.7M150.12M150.05M148.59M150.19M149.1M
Basic Shares Outstanding150.35M150.35M150.24M150.24M149.92M149.83M149.7M149.41M149.04M148.59M148.62M149.1M
Dividend Payout Ratio--21.67%----61.67%68.52%-308.33%-